FDA issued a Warning Letter to Huvepharma Inc on 6/13/2013 as a result of this inspection.
FDA investigators audited the Huvepharma - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 28 Feb 2013.
Product details
- Category: Animal Drugs & Feeds
- Inspection end: 28 Feb 2013
- Location: Saint Louis, United States
- FEI: 1940172
